Sermion is an original Pfizer medicine containing nicergoline, an ergoline derivative with vasoactive properties that improves cerebral and peripheral circulation. It is commonly prescribed to support blood flow, enhance brain metabolism, and help manage chronic vascular disorders affecting cognitive function.
Sermion is available in two strengths:
Active ingredient:
Active ingredient:
Each tablet also contains pharmaceutical excipients that ensure stability and proper absorption.
Nicergoline helps:
Long-term therapy may contribute to better cognitive performance and vascular function.
Sermion may be prescribed for:
Treatment decisions should always be made by a qualified healthcare professional.
Sermion tablets are taken orally.
The dosage depends on:
Long-term treatment is often recommended for chronic vascular disorders.
Some patients may experience:
Consult your healthcare provider if significant adverse effects occur.
Do not use in patients with:
Store at room temperature in a dry place away from moisture and direct sunlight.
Keep out of reach of children.
Sermion is prescribed to improve cerebral and peripheral blood circulation and manage vascular cognitive disorders.
They contain different amounts of nicergoline. Your healthcare provider will determine the appropriate strength.
Yes. Long-term treatment is common when medically indicated and supervised by a physician.
Clinical improvement generally develops gradually over several weeks of regular treatment.
Yes. It is frequently prescribed for elderly patients with chronic cerebrovascular conditions.
In many countries, Sermion is available only with a valid medical prescription.
Ask a question or inquire about delivery to your country



